Donor Antigen-Specific Regulatory T Cell Administration to Recipients of Live Donor Kidneys: A ONE Study Consortium Pilot Trial

As part of the ONE Study consortium, the authors conducted a phase I-II clinical trial in which purified donor antigen reactive-Tregs were administered to three patients, 7 to 11 days after live donor renal transplant.